Mizuho Medy Co.,Ltd.
JPX: 4595.T0.00 n/a
+0.00%(+0.00)
Key facts
- Exchange
- Tokyo Stock Exchange
- Sector
- Healthcare
- Industry
- Drug Manufacturers - Specialty & Generic
- CEO
- Fuminari Karakawa
- Employees
- 187
- Headquarters
- Tosu, Japan
- IPO year
- 2015
- Market cap
- ¥33.4B
- Website
- https://www.mizuho-m.co.jp
Loading 4595…
Loading profile data…Frequently asked questions about 4595
What does Mizuho Medy Co.,Ltd. (4595.T) do?
Mizuho Medy Co.,Ltd. researches and develops, manufactures, and sells in-vitro diagnostic products and related scientific and technical information services primarily in Japan. The company provides immunoassay test products, such as influenza virus kits; RS virus and human metapneumovirus antigen test kits; streptococcus pneumoniae antigen and l...
Where does 4595.T trade?
Mizuho Medy Co.,Ltd. (4595.T) trades on the Tokyo Stock Exchange.
What sector is 4595.T in?
Mizuho Medy Co.,Ltd. (4595.T) operates in the Healthcare sector, specifically in the Drug Manufacturers - Specialty & Generic industry.
Who is the CEO of Mizuho Medy Co.,Ltd.?
Fuminari Karakawa is the chief executive officer of Mizuho Medy Co.,Ltd. (4595.T).
Where is Mizuho Medy Co.,Ltd. headquartered?
Mizuho Medy Co.,Ltd. is headquartered in Japan.
Does 4595.T pay a dividend?
Yes — Mizuho Medy Co.,Ltd. (4595.T) paid a trailing twelve-month dividend of JPY 100.00 per share. Frequency and ex-dividend dates are tracked on the dividends tab.
When did 4595.T go public?
Mizuho Medy Co.,Ltd. (4595.T) completed its initial public offering in 2015.